Answers are grounded in this paper and cite their sources.
Stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (HFSRT) have become important treatment modalities for brain metastases. While effective, there are still areas of extensive debate on its appropriate use in patients with life-limiting diseases. This review provides an overview of the indications and challenges of SRS and HFSRT in the management of brain metastases.
No takes yet. Share an insight, caveat, or question.
Rockhill et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: